Article: Nicotinamide Riboside Protects Neurons More Effectively Than NAD+: Preclinical Findings

PrevNext
Immune Health Metabolic Health Preclinical

Nicotinamide Riboside Protects Neurons More Effectively Than NAD+: Preclinical Findings

Synopsis

Loss of NAD+ is common in neurodegenerative diseases. Excitotoxicity, caused by excessive stimulation of neurons, leads to nerve damage. This study found that nicotinamide riboside (NR), a NAD+ precursor, protects brain neurons better than NAD+ itself against excitotoxic damage caused by NMDA. NR’s protective effects depend on the neuron’s internal NAD+ balance and uptake of NR. This suggests NR is a promising agent for preventing nerve damage in excitotoxic conditions.

Journal

The FASEB Journal

Share

Read more

Cellular Health

Modulating NAD+ Metabolism from Preclinical to Clinical Application: Review

SynopsisFirst discovered in the early 1900s, nicotinamide adenine dinucleotide (NAD+) was once seen only as a helper in energy reactions but is now known to be essential for many regulatory protein...

Read more
Cellular Health

NAD+ in Aging: Molecular Mechanisms and Translational Implications: Review

SynopsisNAD+ is vital for energy production and helping cells adapt to stress, especially in high-energy tissues like the brain. NAD+ levels drop with age, contributing to chronic diseases such as ...

Read more